Showing results (891-900 of 936) with videos related to

Sort By:
Pageof 94
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|June 5, 2002
[Frequency of occurrence of Hepatitis C virus markers and risk factors among hospital personnel in the Novosibirsk region]A V Shustov, G V Kochneva, G F Sivolobova, et al.
Cell Reports|October 4, 2024
ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse modelsSebastian Schmid, Zachary R Russell, Alex Shimura Yamashita, et al.
Nature Communications|October 12, 2018
Complement receptor CD46 co-stimulates optimal human CD8<sup>+</sup> T cell effector function via fatty acid metabolismGiuseppina Arbore, Erin E West, Jubayer Rahman, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Antimicrobial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinaseBright Obeng, Lucas J Bennett, Bailey E West, et al.
Journal of Immunotoxicology|January 16, 2025
Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinaseBright Obeng, Lucas J Bennett, Bailey E West, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffoldWayne D Vaccaro, Rosy Sher, Michael Berlin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2024
Prioritizing sexual and reproductive health research and care for people with cystic fibrosis: A 2023 workshop report from the Cystic Fibrosis Foundation Sexual Health, Reproduction, and Gender (SHARING) Research Working GroupTraci M Kazmerski, Christie Moy, Enid Aliaj, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2025
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosisNatalie E West, Michael W Konstan, Patrick A Flume, et al.
Pageof 94